Literature DB >> 3632921

In vitro activity of cefpirome (HR810) against antibiotic-resistant gram-positive and gram-negative bacteria including organisms with inducible resistance.

P R Murray, A C Niles.   

Abstract

The activity of cefpirome (HR810) was compared with seven beta-lactam antibiotics against selected gram-positive and gram-negative bacteria. Cefpirome was the most active antibiotic tested against all groups of Enterobacteriaceae; 46% of the isolates of Pseudomonas aeruginosa were inhibited by less than or equal to 8 micrograms/ml of cefpirome. Fifty percent of the oxacillin-resistant Staphylococcus aureus isolates and 82% of the Streptococcus faecalis isolates were inhibited by less than or equal to 8 micrograms/ml of cefpirome. All Enterobacteriaceae and two of five P. aeruginosa isolates that were induced to produce beta-lactamase by prior exposure to cefoxitin remained susceptibile to cefpirome.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3632921     DOI: 10.1016/0732-8893(86)90057-x

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  1 in total

1.  Dose linearity testing of intravenous cefpirome (HR 810), a novel cephalosporin derivate.

Authors:  L Maass; V Malerczyk; M Verho; P Hajdú; K Seeger; N Klesel
Journal:  Infection       Date:  1987 May-Jun       Impact factor: 3.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.